| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Clinical Research Centers |
Division of Neonatology (M.E.W.), Georgetown University Medical Center, Washington, DC 20007; Department of Foods and Nutrition (B.R.M., L.A.J., C.M.W.), Purdue University, West Lafayette, Indiana; Indiana University School of Medicine (M.P.), Indianapolis, Indiana; and Department of Chemistry (D.S., X.-Y.J.), University of Nebraska, Lincoln, Nebraska
Address all correspondence and requests for reprints to: Meryl E. Wastney, Ph.D., DRC, Private Bag 3123, Hamilton, New Zealand. E-mail: wastneym{at}drc.co.nz
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The mechanisms involved in the increase in bone retention have not been identified, although both suppression (8) and stimulation (9) of bone remodeling have been proposed. Serum osteocalcin (OC) a marker of bone formation, was decreased by 15% in 7- to 10-yr-old twins given a 25 mmol/day calcium supplement for 3 yr, which increased bone mass, compared with those given placebo (10). However, no changes were observed in serum OC and bone specific alkaline phosphatase (markers of bone formation) or urinary cross-links (bone resorption markers) in adolescent girls whose bone density increased with milk supplementation (4).
Kinetic studies, using calcium tracers, provide a more quantitative measure of bone turnover than bone markers. The purpose of this study was to identify the mechanisms whereby calcium intake increases calcium retention in adolescents, by measuring calcium kinetics, biochemical markers of bone turnover, and serum levels of calcium-regulating hormones in the same girls, on a low and high intake of calcium.
| Materials and Methods |
|---|
|
|
|---|
Healthy, white girls, 1114 yr old (12 ± 1 yr, mean
± SD, n = 10) participated in a study to determine
the relationship between calcium intake and retention, under a
controlled living environment, as described previously
(2). Subject characteristics are given in Table 1
. Exclusion criteria included daily
calcium intakes of greater than 20 mmol, disease affecting calcium
metabolism, use of sex steroid contraceptives, smoking, and weight
outside 85120% of the ideal for age and height. The protocol was
approved by Purdue University and Indiana University School of Medicine
Use of Human Subjects Research Committees. Informed consent was
obtained from subjects and their guardians.
|
Subjects were studied while on a high (47.4 ± 1.2 mmol/day) or low (21.2 ± 2.0 mmol/day) calcium intake, during two 21-day study periods that were separated by 1 month, in randomized order, using a cross-over design. No sequence effect of calcium intake on calcium retention was detected, as discussed previously in detail (2). The high intake was achieved by fruit-flavored beverages containing calcium citrate malate (Proctor & Gamble, Cincinnati, OH), as described previously (2). After a 1-week adaptation to the assigned diet, subjects were administered stable calcium isotope orally (1 mmol of 44Ca as CaCO3) with a breakfast containing one-third of their daily calcium intake, and 1h after the oral dose, iv (0.9 mmol of 42Ca as CaCl2). All urine and feces and 28 blood samples were collected during the 14 days after tracer administration. Compliance of urine and fecal collections was determined by creatinine and PEG recovery, as described previously (2). Calcium was determined in the samples by atomic absorption spectroscopy (5100 PC, Perkin-Elmer Corp., Norwalk, CT), and isotope ratios were determined by fast atom-bombardment mass spectrometry (11).
Biochemical markers of bone turnover
At the end of each 21-day metabolic period, blood was drawn, after an 8-h overnight fast, and left to clot for 30 min. Serum was removed immediately and stored at -70 C. Twenty-four-hour urine collections, at the end of each balance period, were aliquoted and stored at -70 C. Biochemical markers of bone formation (serum OC and serum bone alkaline phosphatase) and biochemical markers of bone resorption [serum tartrate-resistant acid phosphatase, urinary hydroxyproline/creatinine (OHP:Cr), and urinary cross-linked N- teleopeptides of type I collagen] were measured as described previously (12). Pyridinoline (PYR) and total deoxypyridinoline (DPX) were measured by high-performance liquid chromatography (13). Vitamin D metabolites were measured as previously described (14). Creatinine was measured by a Multichannel Analyzer (Roche). Serum PTH 184 was measured by two-site RIA (Nichols Institute Diagnostics, San Juan Capistrano, CA). Insulin-like growth factor 1 (IGF-1) was analyzed by using kits from DSL (Webster, TX).
Data analysis
Tracer data (oral and iv) from serum, urine, and feces were
fitted simultaneously by a three-compartmental model, described
previously (15), using the WinSAAM modeling program
(16). The model (Fig 1
)
consists of compartments representing calcium pools within the body
that turn over at distinct rates. Transfer of calcium between
compartments, L(I, J), was defined as the fraction of compartment J
moving into compartment I per unit time. The mass of calcium
transferred per day, or transport rate, R(I, J), was calculated as the
product of fractional transfer and compartment mass, M(J): R(I, J)
= L(I, J) x M(J). Bone turnover parameters were determined as
described previously (15), including rates of calcium
deposition in bone or bone formation (Vo+),
resorption of calcium from bone (Vo-), and
calcium retention or bone balance (Vbal)
calculated as Vo+ - Vo-.
Rates of calcium absorption (Va), calcium
excretion in urine (Vu), fecal calcium excretion
(VF), and endogenous fecal calcium excretion
(Vf) were also calculated. Absorption was
calculated as the fraction of calcium in the gut (compartment 8) that
entered serum (compartment 1): absorption = L(1, 8)/[L(1, 8) +
L(9, 8)].
|
Data were fitted for each subject while on the low calcium intake. Then, the minimum number of parameters necessary to fit data, obtained while the subjects were on high calcium intake, were changed. One subject was excluded from analysis of kinetic data, because she was not compliant in collecting urine and fecal samples (PEG recovery < 80%).
Population values for kinetic parameters were determined using the multiple studies feature of the SAAM program (17). Paired t tests were used to compare the effect of calcium intake on biochemical measures. Significant differences were determined to be P < 0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Mechanisms
The large increase in amount of calcium absorbed on the high calcium intake occurred because fractional absorption did not decrease with higher calcium intake. Net absorption in a larger sample of adolescent girls (n = 35, 12.7 ± 1.2 yr) (2) are in agreement with these results, in showing only a small change (from 0.32 to 0.28) in fractional absorption at 21.2 vs. 47.4 mmol/day intake. This result is contrary to the significant decrease in absorption with calcium intake observed in subjects 35 yr old (21), 816 yr old (22), 2124 yr old (19), or 3545 yr old (23). Thus, the inverse relationship between fractional absorption and intake may not hold in rapidly growing adolescents undergoing the pubertal growth phase. Also, the relationship may function only at lower calcium intakes, because a strong negative relationship was reported between fractional absorption and calcium intake less than 25 mmol/day in white girls but not at intakes greater than 25 mmol/day (24). The higher absorption reported here and previously (15) from breakfast, compared with the whole day, is probably related to the overnight fast. Birge et al. (25) reported that absorption from a 8.2-mmol calcium load was 54% after an overnight fast but was reduced to 33% when a meal was given 2.5 h before the measurement. Fractional absorption was also inversely related to the amount of calcium in the previous meal (25).
Our studies on 12 yr olds, studied on controlled intakes in a cross-over design, showed that retention was increased through suppression of bone resorption. These results differ from a cross-sectional study in girls 518 yr old, which showed that bone turnover increased with absorbed calcium (up to 16.2 mmol/day), with deposition increasing faster than resorption (9). The lack of change in bone formation markers and the decrease in a marker of resorption support our results, showing that bone formation does not change and that resorption suppresses with high calcium intake. OBrien et al. (22) also reported that urinary telopeptides were lower in girls on a calcium intake of 35 mmol/day than 7 mmol/day. Two other markers of bone resorption, urinary PYR:Cr and urinary DPX:Cr, were reduced significantly in a larger sample (n = 25;1215. yr) while on high (4252 mmol/day), compared with low (2134 mmol/day), calcium intakes (unpublished data).
Bone turnover and retention are known to decrease with postmenarcheal age (14, 15, 26); and as shown here and previously (2), the largest impact of calcium intake on calcium retention occurs within the first 6 months of onset of menarche. Therefore, as adolescents approach adulthood, their response to calcium intake will change, such that retention will increase less with calcium intake.
Relationship of kinetic and biochemical changes
Biochemical markers of bone turnover are predictive of Vo+ and Vo- (27). Resorption markers are sensitive to bone loss and decreases are measured over 6 h, after a 25-mmol oral calcium load (28), and increases are measured within days of initiation of bed rest or space flight (29). Changes in the diurnal rhythm of resorption markers have also been observed after 2 wk of calcium administration (30). By contrast, after 1 yr of calcium administration to older women, only bone formation markers were changed (31). We found that, in young girls, changes in markers of bone resorption were variable, ranging from -11 to -23% and were lower than the calculated change of -32% in bone resorption on the higher calcium intake. The most predictive marker of bone resorption was hydroxyproline, which decreased by 23%, which was still quite short of the 32% change in resorption measured by kinetics. Thus, biochemical markers of bone resorption were not quantitatively in agreement with each other but also underestimated changes in bone resorption in response to diet and, in most cases, were unable to show a statistically significant effect. Similarly, markers were not changed after prolonged (18 mo) dairy supplementation to girls, although bone mass increased (4). Because marker levels change significantly with stage of sexual maturity (32), some changes in markers caused by calcium intake may be masked by stage of maturity. However, the effect of stage of maturity is minimized in our study by use of within-subject comparisons over a relatively brief study period of 2 months.
We found no changes in serum PTH, vitamin D metabolites, or IGF-1. Dietary calcium influenced the amount of absorbed calcium without influencing these mediators of absorption, but the effect was to suppress bone resorption. Osteoclasts respond directly to extracellular calcium in vitro (33). Whether delivery of calcium to bone is a factor acting locally is not clear. We found decreases in total serum calcium, but this does not preclude an increase in local free calcium.
In summary, calcium intake can profoundly increase bone balance, especially close to onset of menarche. This enhanced bone retention of calcium with calcium intake in adolescent girls is attributable to increased absorption of calcium, combined with decreased bone resorption. At this period in a womans life, when bone turnover is at its maximum, the sum of bony resorption and dietary calcium absorption is essentially constant. Therefore, what does not come from the diet comes from the skeleton. This study lends further support to the importance of achieving adequate dietary calcium during this life stage.
| Footnotes |
|---|
Received March 11, 2000.
Revised June 6, 2000.
Revised August 8, 2000.
Accepted August 20, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. A. Atkinson, G. P. McCabe, C. M. Weaver, S. A. Abrams, and K. O. O'Brien Are Current Calcium Recommendations for Adolescents Higher than Needed to Achieve Optimal Peak Bone Mass? The Controversy J. Nutr., June 1, 2008; 138(6): 1182 - 1186. [Full Text] [PDF] |
||||
![]() |
M. Braun, C. Palacios, K. Wigertz, L. A Jackman, R. J Bryant, L. D McCabe, B. R Martin, G. P McCabe, M. Peacock, and C. M Weaver Racial differences in skeletal calcium retention in adolescent girls with varied controlled calcium intakes Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1657 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Heaney and C. M. Weaver Newer Perspectives on Calcium Nutrition and Bone Quality J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 574S - 581S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Heaney Measuring What Isn't There Clin. Chem., November 1, 2005; 51(11): 2003 - 2004. [Full Text] [PDF] |
||||
![]() |
A. Prentice, F. Ginty, S. J. Stear, S. C. Jones, M. A. Laskey, and T. J. Cole Calcium Supplementation Increases Stature and Bone Mineral Mass of 16- to 18-Year-Old Boys J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3153 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Matkovic, P. K Goel, N. E Badenhop-Stevens, J. D Landoll, B. Li, J. Z Ilich, M. Skugor, L. A Nagode, S. L Mobley, E.-J. Ha, et al. Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial Am. J. Clinical Nutrition, January 1, 2005; 81(1): 175 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L Newmark, R. P Heaney, and P. A Lachance Should calcium and vitamin D be added to the current enrichment program for cereal-grain products? Am. J. Clinical Nutrition, August 1, 2004; 80(2): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Weaver 2003 W. O. Atwater Memorial Lecture: Defining Nutrient Requirements from a Perspective of Bone-Related Nutrients J. Nutr., December 1, 2003; 133(12): 4063 - 4066. [Full Text] [PDF] |
||||
![]() |
J. F. Staub, E. Foos, B. Courtin, R. Jochemsen, and A. M. Perault-Staub A nonlinear compartmental model of Sr metabolism. I. Non-steady-state kinetics and model building Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R819 - R834. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dibba, A. Prentice, M. Ceesay, M. Mendy, S. Darboe, D. M Stirling, T. J Cole, and E. M. Poskitt Bone mineral contents and plasma osteocalcin concentrations of Gambian children 12 and 24 mo after the withdrawal of a calcium supplement Am. J. Clinical Nutrition, September 1, 2002; 76(3): 681 - 686. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |